Dr Reddy's profit misses view as emerging markets sales fall | Reuters

MUMBAI Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, reported a quarterly profit that was below analysts' estimates due to a drop in sales, mainly in emerging markets.Net profit for the July-September quarter was 3.09 billion rupees ($46.20 million), while analysts, on average, had expected a profit of 3.5 billion rupees, according to Thomson Reuters data.Sales fell in most of Dr Reddy's markets, especially the emerging market countries that include Russia and Romania, where they were down 27 percent in value terms. India was the only bright spot, witnessing a 14 percent rise in sales

Reuters October 25, 2016 22:04:13 IST
Dr Reddy's profit misses view as emerging markets sales fall
| Reuters

Dr Reddys profit misses view as emerging markets sales fall
 Reuters

MUMBAI Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, reported a quarterly profit that was below analysts' estimates due to a drop in sales, mainly in emerging markets.Net profit for the July-September quarter was 3.09 billion rupees ($46.20 million), while analysts, on average, had expected a profit of 3.5 billion rupees, according to Thomson Reuters data.Sales fell in most of Dr Reddy's markets, especially the emerging market countries that include Russia and Romania, where they were down 27 percent in value terms. India was the only bright spot, witnessing a 14 percent rise in sales.

While currency fluctuations have hurt emerging market sales, Dr Reddy's has also struggled to revive business in its largest market of North America, since regulators imposed import restrictions on some of its drug factories over quality compliance concerns last year. That has hurt profit at a time when competition in the global generics market has intensified.Increased competition in the market for the antiviral valganciclovir hurt second-quarter sales, Dr Reddy's said in a statement on Tuesday. The company's financial year runs from April to March.

Chief Executive GV Prasad said the company had made "considerable progress" in its efforts to remediate issues found at its drug factories.

($1 = 66.8800 Indian rupees) (Reporting by Zeba Siddiqui in Mumbai; Editing by Sherry Jacob-Phillips and Muralikumar Anantharaman)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

also read

Taliban thanks world for emergency aid, urges US to show 'heart' towards Afghanistan
World

Taliban thanks world for emergency aid, urges US to show 'heart' towards Afghanistan

A donor conference in Geneva on Monday saw countries promise a total of $1.2 billion in aid for Afghanistan, which was taken over by the hardline Islamist group last month in a lightning offensive that took retreating US troops by surprise.

Kamala Harris to 'reinforce' India-US strategic partnership in meeet with Narendra Modi: White House
World

Kamala Harris to 'reinforce' India-US strategic partnership in meeet with Narendra Modi: White House

Since taking office, US vice president Kamala Harris has met with or spoken to over thirty world leaders, promoting US interests on issues ranging from global health to climate change to cyber threats

Australia cuts French submarine deal for US nuclear fleet; Scott Morrison cites 'changed strategic environment' as reason
World

Australia cuts French submarine deal for US nuclear fleet; Scott Morrison cites 'changed strategic environment' as reason

Australia's submarine upgrade was a response to China’s takeover of the South China Sea, aggressive bullying of Australia and intimidation of Japan and Taiwan, said Peter Jennings.